EP3383920
Æxlis-sértæk hleðsludreifing og ónæmisvirkjun með því að nota mennskt mótefni sem miðar á mjög sértækan æxlis-frumuyfirborðs-mótefnavaka
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.11.2016EP published:
10.1.2024EP application number:
16871367.5
EP translation filed:
8.4.2024Grant published:
15.5.2024EPO information:
European Patent Register
Max expiry date:
28.11.2036Expiry date:
28.11.2026Next due date:
30.11.2026
Title in English:
TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGENLanguage of the patent:
English
Timeline
Today
29.11.2016EP application
10.1.2024EP Publication
8.4.2024Translation submitted
15.5.2024Registration published
28.11.2026Expires
Owner
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200, US
Inventor
Name:
LIU, BinAddress:
San Francisco, California 94127, US
Name:
BIDLINGMAIER, ScottAddress:
San Francisco, California 94123, US
Name:
SU, YangAddress:
South San Francisco, California 94080, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562261112 PDate:
30.11.2015Country:
US
Classification
Categories:
C07K 16/40, C07K 14/725, C12N 5/0783, A61K 35/17, A61K 35/00, C07K 16/28, C12N 9/16, G01N 33/574, A61K 39/00, A61K 47/68, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 31.10.2024
Expires: 28.11.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 24.11.2025
Expires: 28.11.2026
Payer: Árnason Faktor ehf.